跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRX-2
首页
药物
TRX-2
TRX-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method of treating TRX mediated diseases
US 2006009526 A1
申请人: RICHON VICTORIA M
优先权: 2003
US
3 件公开
6-dithio-substituted-2′-deoxyguanosine compound, preparation method thereof and use thereof
US 11247994 B2
申请人: UNIV ZHEJIANG
优先权: 2018
CN
US
2 件公开
EXPRESSION VECTOR FOR RECOMBINANT U-CONOTOXIN THIA OR TIIIALAMUT EXPRESSION IN E.COLI
WO 2025057018 A4
申请人: SCIENCE4BEAUTY SP Z O O
优先权: 2023
CN
WO
2 件公开
Gene engineering body for somatostatin gene engineering subunit seedling
CN 1372000 A
申请人: NANJING NANNONG HIGH SCIENCE A
优先权: 2002
CN
Compounds and methods for reducing undesired toxicity of chemotherapeutic agents
US 2009111735 A1
申请人: BIONUMERIK PHARMACEUTICALS INC
优先权: 2008
US
Bursin specific binding peptide and screening method thereof
CN 101412750 B
申请人: UNIV NANJING AGRICULTURAL
优先权: 2008
CN
Recombinant human insulin-like growth factor-2 protein and production method thereof
CN 102936602 A
申请人: GUANGZHOU INST BIOMED & HEALTH
优先权: 2012
CN
Monoclonal antibody and preparation method thereof
CN 106397581 A
申请人: BINZHOU MEDICAL COLLEGE
优先权: 2016
CN
一种戈氏梭菌特异性PCR检测引物及方法
CN 106868024 B
申请人: 山东新创生物科技有限公司
优先权: 2017
CN
P49 mutant protein of African swine fever virus immunogen, recombinant vector, escherichia coli genetically engineered bacterium, preparation method and application
CN 111875676 A
申请人: ZHEJIANG NOVO BIOTECH CO LTD
优先权: 2020
CN
第 1 / 3 页
上一页
下一页
药物
反馈